Last checked at 18 May 2020 14:43
For immediate release | 18 May 2020 |
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Result of AGM
Alliance Pharma plc (AIM: APH), the international healthcare group, announces that at its Annual General Meeting held on 18 May 2020, all the resolutions, as set out in the Notice of Meeting, were duly passed on a poll.
The votes were as follows:
RESOLUTION | VOTES FOR | % | VOTES AGAINST | % | VOTES TOTAL | % OF ISC VOTED | VOTES WITHHELD | |
1 | Report and Accounts | 307,119,531 | 87.77 | 42,803,894 | 12.23 | 349,923,425 | 65.90 | 341,086 |
2 | Re-elect D. Cook | 348,362,753 | 99.46 | 1,894,143 | 0.54 | 349,923,425 | 65.96 | 7,615 |
3 | Re-elect P. Butterfield | 350,252,415 | 99.99 | 7,502 | 0.01 | 350,259,917 | 65.97 | 4,594 |
4 | Re-elect A. Franklin | 350,126,924 | 99.97 | 118,638 | 0.03 | 350,245,562 | 65.96 | 18,949 |
5 | Re-elect N. Clifford | 302,972,623 | 87.53 | 43,167,791 | 12.47 | 346,140,414 | 65.19 | 4,124,097 |
6 | Re-elect J. LeCouilliard | 349,230,711 | 99.71 | 1,014,851 | 0.29 | 350,245,562 | 65.96 | 18,949 |
7 | Re-elect R. Jones | 349,908,539 | 99.90 | 334,002 | 0.10 | 350,242,541 | 65.96 | 21,970 |
8 | Re-appoint Auditor | 350,203,002 | 99.99 | 35,502 | 0.01 | 350,238,504 | 65.96 | 26,007 |
9 | Remuneration of Auditor | 350,241,261 | 99.99 | 14,619 | 0.01 | 350,255,880 | 65.96
| 8,631 |
10 | Allot shares | 340,262,574 | 97.15 | 9,995,811 | 2.85 | 350,258,385 | 65.97 | 6,126 |
11 | Disapply Pre-emption rights | 297,541,849 | 84.95 | 52,716,536 | 15.05 | 350,258,385
| 65.97
| 6,126 |
12 | New Articles | 350,228,320 | 99.99 | 2,264 | 0.01 | 350,230,584 | 65.96 | 33,927 |
The number of the Group's shares in issue as at the date of the meeting was 530,975,807 ordinary shares of 1p each.
Please note that each share carries one vote and that a 'vote withheld' is not a vote in law and has not been counted in the calculation of the proportion of the votes for and against the resolution. Any proxy appointments which gave discretion to the Chairman have been included in the 'votes for' total.
Chris ChrysanthouHead of Legal & Company Secretary18 May 2020
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
Peter Butterfield, Chief Executive Officer
Andrew Franklin, Chief Financial Officer
www.alliancepharma.co.uk
Buchanan + 44 (0) 20 7466 5000
Mark Court / Hannah Ratcliff
Numis Securities Limited + 44 (0) 20 7260 1000
Nominated Adviser: Freddie Barnfield / Huw Jeremy
Corporate Broking: James Black
Investec Bank plc +44 (0) 20 7597 5970
Corporate Finance: Daniel Adams / Ed Thomas
Corporate Broking: Patrick Robb / Tejas Padalkar
About Alliance Pharma
Alliance Pharma plc (AIM: APH) is an international healthcare group, headquartered in the UK with subsidiaries in Europe, the Far East and the US and wide international reach through an extensive network of distributors, generating revenues in more than 100 countries.
We currently own or license the rights to around 90 consumer healthcare products and pharmaceuticals, which are managed on a portfolio basis according to their growth potential. Promotional investment is focused on a small number of brands with significant international or multi-territory reach. The remainder of the portfolio comprises products which are sold in a limited number of local markets and require little or no promotional investment.
Our strategy allows us to deliver good organic growth and to enhance our growth rate through carefully selected acquisitions.
For more information on Alliance, please visit our website: www.alliancepharmaceuticals.com